KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
- Yemen’s Houthis Target Israel’s Main Airport Three Times Within 48 Hours
- Urgent: Yemen’s Houthis Claim Missile Attack On Israel’s Ben Gurion Airport
- U.S. New Anti-Iran Sanctions Not Compatible With Nuclear Talks: Spokesman
- Islamic Jihad Launches Rockets At Israeli Cities In Response To Gaza Hospital Strikes
- More than 83 mn people internally displaced worldwide: monitor
- 18 Suspected Armed Separatists In Indonesia Killed In Military Strike
- New Zealand Maori Party MPs Suspended From Parliament Over Haka Protest
- Turkish, Ukranian FMs Met On Upcoming Russia-Ukraine Peace Talks
- One Killed, 12 Injured In Hand Grenade Attack In SW Pakistan
- Pakistan, India Expel Each Other’s Diplomats